3ZAUDIG M. A risk- benefit assessment of risperidone for treatment of behavioural and psychological symptoms in dementia[J].Drug Saf, 2000, 23(3), 183-195.
4COLERICK EJ, GEORGE LK. Predictors of institutionalization among caregivers of patients with Alzheimer's disease[J]. J Am Geriatr Soc , 1986, 34(4): 493-498.
5BALLARD CG, MARGALLO-LANA M, FOSSEY J, et al. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments[J]. J Clin Psychiatry, 2001, 62(8): 631-636.
6COHEN-MANSFIELD J. Assessment of disruptive behavior/agitation in elderly: function, methods and difficulties[J].J Geriatr Psychiatry Neurol, 1995, 8 (1): 52-60.
7CHAN WC, LAM LC, CHOY CN, et al. A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients[J]. Int J Geriatr Psychiatry, 2002, 17(11): 1076-1077.
8de DEYN PP, RABHERU K, RASMUSSEN A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia[J]. Neurology, 1999, 53(5): 899-901.
9KATZ IR, JESTE DV, MINTZER JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double- blind trial[J]. J Clin Psychiatry, 1999, 60(2): 107-115.
